1. Can Endangered Biosimilar Markets be Rescued? The Need to Bridge Competing Interests for Long-Term Gain

   • Teresa Barcina Lacosta
   • Arnold G. Vulto
   • Steven Simoens

   Commentary 26 February 2024 Pages: 325 - 329

2. Additional Data in Expanded Patient Populations and New Indications Support the Practice of Biosimilar-to-Biosimilar Switching

   • Hillel P. Cohen
   • Wolfram Bodenmueller

   Current Opinion Open access 23 March 2024 Pages: 331 - 339

3. Next-Generation Anti-TNFα Agents: The Example of Ozoralizumab

   • Kouhei Tsumoto
   • Tsutomu Takeuchi

   Review Article Open access 08 April 2024 Pages: 341 - 351

   

4. Research Advances in Stem Cell Therapy for Erectile Dysfunction

   • Wei Wang
   • Ying Liu
   • Cong-hui Han

   Review Article Open access 23 March 2024 Pages: 353 - 367

   

5. Targeted Gene Insertion: The Cutting Edge of CRISPR Drug Development with Hemophilia as a Highlight

   • Zhenjie Zhang
   • Siqi Zhang
   • Bo Feng

   Review Article Open access 15 March 2024 Pages: 369 - 385

   

6. CRISPR-Cas System: A New Dawn to Combat Antibiotic Resistance

   • Muhammad Shahzad Rafiq
   • Muhammad AbuBakar Shabbir
   • Haihong Hao

   Review Article 11 April 2024 Pages: 387 - 404

   

7. Use of Biosimilars: A Systematic Review of Published Position Statements and Recommendations from Health Organisations and Societies

   • Noraisyah Mohd Sani
   • Zoriah Aziz
   • Adeeba Kamarulzaman

   Systematic Review 12 March 2024 Pages: 405 - 423

   

8. Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database

   • Paola Maria Cutroneo
   • Elena Arzenton
   • Gianluca Trifirò

   Original Research Article Open access 15 March 2024 Pages: 425 - 448

   

9. Consensus-Based Overarching Principles and Recommendations on the Use of Biosimilars in the Treatment of Inflammatory Arthritis in the Gulf Region

   • Khalid A. Alnaqbi
   • Nasra Al Adhoubi
   • Tore K. Kvien

   Original Research Article Open access 25 February 2024 Pages: 449 - 463

   

10. Impact of Early Access Reform on Oncology Innovation in France: Approvals, Patients, and Costs

    • Tess Martin
    • Catherine Rioufol
    • Isabelle Borget

    Original Research Article 20 April 2024 Pages: 465 - 475